• Analysing humoral and cellular immune responses to vaccination during chronic infection
• Attitudes to, and Understanding of Risk of Acquisition of HIV over time (AURAH2)
• The COURRAGE to change: tackling women’s depression and poverty through storytelling for social change (COURRAGE)
• DISCOVER: A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection (GS-US-412-2055)
• From Coping to Transformation: Can brief intervention treatment models create a platform for action against social determinants of mental health? An ethnographic evaluation study in South Africa
• HIPvac: Randomised controlled trial of Imiquimod cream vs. podophyllotoxin in combination with quadrivalent HPV or control vaccination in the treatment and prevention of recurrence of anogenital warts
• The Integrated Sustainable Childhood Pneumonia and Infectious disease Reduction in Nigeria (INSPIRING) programme evaluation and research
• Partners of people on ART - a New Evaluation of the Risks (The PARTNER study)
• PrEP IMPACT Trial: A pragmatic health technology assessment of PrEP and implementation
• Safetxt: A randomised controlled trial of an intervention delivered by mobile phone messaging to reduce sexually transmitted infections (STI) by increasing sexual health precaution behaviours in young people
• SEPAC: Screening and early detection to prevent anal cancer; development of a biomarker screening tool
• SIREN (Sarscov2 Immunity & REinfection EvaluatioN)